The global anemia drugs market is witnessing strong growth, driven by the rising prevalence of anemia worldwide, increasing awareness of treatment options, and advancements in drug formulations. The market was valued at USD 11.22 billion in 2023 and is projected to reach USD 12.25 billion in 2024, growing further to USD 23.74 billion by 2031 at a CAGR of 9.91% during the forecast period...
Future Anemia Drugs Market: Key Dynamics, Size & Share Analysis
The Global Anemia Drugs Market size was valued at around USD 14.62 billion in 2024 and is projected to reach USD 21.73 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 6.83% during the forecast period, i.e., 2025-30. The main reason behind this growth is the rising anemia...
The global anemia drugs market is poised for substantial expansion in the coming years, driven by a rising prevalence of anemia, growing awareness about early diagnosis, and increasing adoption of advanced therapeutic approaches. According to Kings Research, the global anemia drugs market size was valued at USD 11.22 billion in 2023 and is projected to grow from USD 12.25 billion in 2024 to USD...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek